Diverse types of dermatologic toxicities from immune checkpoint blockade therapy
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Cutaneous Pathology"
DOI: 10.1111/cup.12858
Abstract: Immunomodulatory drugs that leverages host immune mechanisms to destroy tumor cells have been met with great promise in the treatment of cancer. Immunotherapy, targeting cytotoxic T‐lymphocyte‐associated antigen 4 (CTLA‐4) and the programmed cell death 1… read more here.
Keywords: immune checkpoint; diverse types; patients receiving; types dermatologic ... See more keywords